Shanghai Shen Lian Biomedical Corp. engages in the research, development, and manufacture of vaccines for the animal farming industry. Its products include synthetic peptide vaccines for the foot-and-mouth disease of pigs and new vaccines. The company was founded on June 28, 2001 and is headquartered in Shanghai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company